A health insurance dispute is preventing a North Carolina man from getting a cancer drug his doctors say is necessary.

The move has angered some doctors, particularly those who often see older, medically complicated patients in need of more ...

In this week’s edition of InnovationRx, we look at a high-tech chair that could revolutionize cancer radiation therapy, AI ...

(Billable Hours is Reuters' weekly report on lawyers and money. Please send tips or suggestions to ...

It’s not enough to ask what the technology can theoretically do. Leaders should press vendors on precisely what the workflow ...

The University of Maine System is switching to Anthem health insurance for its employees, even though the insurer has been ...

Thinking about what to do with Cigna Group stock right now? You are not alone. Investors have been watching the company’s ...

The Cigna Group (NYSE:CI) is one of the 11 Dirt Cheap Stocks to Buy According to Analysts. On October 15, Wolfe Research ...

Elevance Health (ELV) stock gains, boosting its peers as the company beats Street forecasts with its Q3 2025 results. Read ...

More than a dozen S&P 500 companies are heading into next week’s earnings reports with earnings-per-share forecasts that have been raised sharply in ...

Cigna will monitor doctors who charge higher fees for patient visits starting October 1st. The insurance company plans to ...

Investing.com -- Moody's Ratings has affirmed The Cigna Group's senior unsecured debt rating at Baa1, maintaining a stable outlook for the health services company and its subsidiaries.